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Abstract 
The essential oil from leaves of Minthostachys verticillata was obtained by steam distillation and analyzed by gas chromatography. Peripheral blood 
mononuclear cells from allergic patients were stimulated with essential oil. By application of MTT or 3,(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium 
bromide colorimetric test the proliferation was assayed. In lymphocyte cultures CD4+, CD8+ and B cells were quantified, and in supernatants, IFN-γ and IL-
13. The liberation of β-hexosaminidase enzyme was determined for basophils with essential oil added and challenged with allergen and its effects were 
compared with those of anti-allergic drugs. The main constituents identified were pulegone, menthone and limonene. Essential oil increased absolute values 
of CD4+, CD8+ and B cells (p<0.002), stimulated IFN-γ synthesis and reduced IL-13 levels. Essential oil diminished β-hexosaminidase liberation by basophils 
(p<0.0001), with effects majors to those of the drugs tested. Essential oil stimulated the Th1 deviation and reduced β-hexosaminidase enzyme liberation by 
basophils from allergic patients. 
Keywords: Minthostachys verticillata; Essential oil; Immunomodulator; Basophil degranulation; β-hexosaminidase. 
Resumen 
El aceite esencial de hojas de M. verticillata fue obtenido por destilación en corriente de vapor y analizado por cromatografía gaseosa. Células 
mononucleares de sangre periférica de pacientes alérgicos, fueron estimuladas con aceite esencial. La proliferación fue ensayada mediante método 
colorimétrico del MTT o 3,(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide. Se cuantificaron células CD4+, CD8+ y B en cultivos de linfocitos y 
en sobrenadantes, IFN-γ e IL-13. Se determinó la liberación de la enzima β-hexosaminidasa de basófilos adicionados de aceite esencial, y desafiados con el 
alergeno. Los efectos del aceite esencial fueron comparados con los de drogas antialérgicas. Los principales constituyentes identificados fueron pulegona, 
mentona y limoneno. Aceite esencial incrementó los valores de células CD4+, CD8+ y B (p<0.002), estimuló la síntesis de IFN-γ y redujo los niveles de IL-13. 
El aceite esencial disminuyó la liberación de β-hexosaminidasa de basófilos (p<0.0001) con mayores efectos que los de las drogas ensayadas. Aceite esencial 
estimuló la desviación Th1 y redujo la liberación de la enzima β-hexosaminidasa de basófilos de pacientes alérgicos. 
Palabras Clave: Minthostachys verticillata; Aceite esencial; Inmunomodulador; Desgranulación de basófilos; β-hexosaminidasa. 
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INTRODUCTION 
Allergic pathologies occur at an incidence of up to 
30% in the population. Allergic patients are generally 
treated with corticoids and/or antihistamines, which 
constitute the anti-inflammatory therapies of choice 
because they block many inflammatory routes that are 
abnormally activated in this type of pathology (Barnes, 
2001). Nevertheless, these methods are not always 
effective and can produce several adverse effects. 
Corticoids suppress both the innate inflammatory 
response and cellular immunity, inhibiting synthesis of 
IL-1, on behalf of macrophages, and of IL-2, on behalf 
of T cells. A correlation has also been discovered 
between their anti-lymphoproliferative effects and 
capacity to produce apoptosis in lymphocyte 
populations (Winiski et al., 2007). 
Antihistamines can produce diverse adverse effects 
such as anemia or reduced platelets, reduced white 
cells and bone marrow failure (Leonardi et al., 2007). 
 In addition, some allergic patients display no 
response to treatment with these drugs, which, in 
conjunction with the fact that this resistance has also 
been observed in other inflammatory diseases (Barnes, 
2001), justifies the search for new immunomodulators. 
A quarter of the drugs used in industrialized countries 
are obtained from the Plant Kingdom. Current 
investigations aim to find plant/herbal medicines 
whose therapeutic indices: permit phytomedicinal 
application, are low-priced and do not bring about 
adverse reactions or undesirable indirect effects, in 
order to be administered as an alternative or 
complementary therapy for conventional treatments. 
Several in vitro or in vivo investigations have 
demonstrated that different extracts or pure 
compounds derived from medicinal plants can 
modulate the Th1/Th2 response, towards the Th1 
profile, producing a beneficial effect for allergic 
patients (Na et al., 2002; Ko et al., 2004; Lee et al., 
2006; Park et al., 2009). 
Minthostachys verticillata (Griseb.) Epling, 
(Labiatae) commonly referred to as ‘peperina', has a 
wide geographical distribution and is known for its 
ethno-medicinal properties. It is used as a digestive, a 
sedative, an anti-spasmodic, a stimulant and a 
bronchial-dilating agent (Ratera & Ratera, 1980). 
 Previous studies have revealed that the essential oil 
derived from this herb presents antimicrobial activity 
against some staphylococcal strains and antiviral 
properties against HSV-1, strain RC/79 of PrV and 
Herpes Suis Virus (Primo et al., 2001). Furthermore, in 
an in vitro study carried out on patients allergic to 
environmental fungi, essential oil, in concentrations of 
mg/mL, revealed mitogenic properties similar to those 
of PWM on human lymphocytes (Cariddi et al., 2005), 
were able to stimulate CD8+ T cells, increased levels 
of IFN-γ and demonstrated anti-allergic properties 
majors to those of dexamethasone and theophylline 
(Cariddi et al., 2006). 
The purpose of this investigation was to determine 
if the essential oil from M. verticillata, at concentra-
tions smaller than previously evaluated, can modulate 
the Th1/Th2 response in allergic patients with history 
of allergies and asthma, and to verify if it maintains its 
inhibiting properties on basophil degranulation in 
these patients, comparing its effects with those of 
conventional anti-allergic drugs. 
MATERIALS AND METHODS 
Plant samples 
 Green leaves and thin stems of Minthostachys 
verticillata (Griseb.) Epling (Labiatae) were collected, 
during morning hours, from the city Santa Rosa in the 
Córdoba province, Argentina, in April 2004. The plant 
was identified by Dr. Margarita Grosso, professor in 
the Area of Botany of the Universidad Nacional de Río 
Cuarto, and a voucher specimen was stored in the 
RCV (Río Cuarto Vasculares) herbarium as file #1955. 
The morphological characterization of the plant was 
executed macro-and microscopically to confirm the 
identity of these specimens. The aerial parts of the 
plant were made up of the leaves and parts of the stem. 
The oil was isolated from the aerial parts. 
Oil isolation 
To prepare the essential oil (EO), 60 g of ground 
plant material were hydro-distilled for 3 h using a 
Clevenger-type apparatus, yielding 4.8% of the oil. 
The oil was separated from the aqueous phase, dried 
over anhydrous Na2SO4 and stored in the dark at -20 
°C until use (Senatore, 1998). In order to perform the 
immunological in vitro assays, various concentrations 
were obtained, and the oil was emulsified in 
dimethylsulfoxide (DMSO) and diluted in Roswell 
Park Memorial Institute (RPMI-1640) medium. 
Identification and quantification of EO compounds 
by Gas chromatography (GC) 
Quantification of components present in the oil 
sample was made by measuring the area under each 
peak of the chromatogram (Zygadlo et al., 1996; 
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Cariddi et al., 2007). Briefly, analytical GC was 
performed on a Shimadzu GC-R1A gas chromato-
graph fitted with a DB5 capillary column (30 x 0.25 
μm). Carrier gas N2, flow rate 1.5 mL/min, split mode. 
Oven temperature programmed from 40–260 ºC at 3 
ºC/min. Injector temp 280 ºC. Detector used FID, 
temperature 300 ºC. The identification of the 
compounds was made comparing their retention times 
against standard pure drugs injected in the same 
conditions.  
Human blood sample 
The sample included peripheral blood mononuclear 
cells (PBMCs) and basophils from 57 allergic patients, 
27 male and 30 female (ages 1 to 30, average value: 
17) with positive prick tests for allergy to dust mites 
(Dermatophagoides pteronyssinus, Dermatophagoides 
farinae). This study was approved by the Universidad 
Nacional de Río Cuarto Institutional Review Board. In 
accordance with ethical standards, parents of underage 
children were properly informed of the study and 
signed an agreement authorizing the test. The 
characteristics of these patients are shown in Table 1. 
Skin prick testing was performed using a standard 
technique (single-headed lancet technique) and 
standard commercial solutions (International 
Pharmaceutical Immunology SA). All tests were 
performed by a single operator, an allergist doctor. 
Each patient underwent skin prick testing for 
allergens. Saline solutions and histamine were used as 
negative and positive controls, respectively. The size 
of the wheal was measured after 15 min and a positive 
result was noted if the wheal size was at least 3 mm 
greater than the negative saline control (Barbaud 
2001). The allergen extracts were provided by 
International Pharmaceutical Immunology, S.A. 
(Alicante, Spain)  Dropper vials were used, containing 
3 mL of the antigen extract in 50% glycerin solution, 
plus 0.42% phenol each (concentration = 10.000 
PNU/mL). The in vitro assays were performed with 
the same extracts. Ten milliliters of venous peripheral 
blood were obtained from each patient and stored in 
sterile tubes containing heparin.  
PBMCs cultures 
 The effects of different concentrations (6 x 103, 
600, 60, 6, 0.6, 0.06 and 0.006 μg/mL) of EO on the 
proliferation of lymphocyte from healthy individuals 
were evaluated. A dose-response curve was construc-
ted in a previous in vitro assay. EO visibly 
demonstrated lymphoproliferative capacity, with dose-
dependency. The concentration of 6 μg/mL obtained 
constituted the highest Proliferation Index (PI) 
PBMCs were isolated from blood samples using 
Ficoll-Hypaque (Hystopaque®-1077; Sigma, St. Louis, 
US) centrifugation. The cellular proliferation assays 
were carried out with the Vybrant® MTT Cell 
Proliferation Assay Kit (Molecular Probes Invitrogen 
Detection Technologies, Eugene, Oregon, USA). Cells 
(2 x 105/mL), with a final volume of 200 µl, were 
cultured in 96-well sterile microplates containing 
RPMI-1640, to which was added 25 mM Hepes, 2 mM 
L-glutamine, 5% FCS, 50 mM 2-ME, 100 μg/mL 
streptomycin and 100 μg/mL penicillin (Merck). 
Cultures were stimulated with 10 µg/mL PHA, 5 
µg/mL ConA and 6 µg/mL oil. Control lymphocyte 
cultures were performed using only media.  
Cells were incubated during 72 h at 37 °C with 5% 
CO2 in a humid atmosphere. An aliquot of 100 μL of 
fresh RPMI-1640 and 10 μL of MTT (3,(4,5-dimethyl-
2-thiazolyl)-2,5-diphenyl tetrazolium bromide) 
solution (1 mg/mL of MTT in PBS 0.01 M pH 7.2) 
was added to each well and the plate was incubated at 
37 °C with 5% CO2 for 4 h. After incubation, the plate 
was centrifuged and supernatants, removed. DMSO 
(50 µL) was added to each well in order to dissolve the 
formazan crystals that resulted from the conversion of 
the salt (MTT). The plate was read in a UV 
spectrophotometer (Labsystems Multiskan MS) at 
570/690 nm wave lengths.  
The cellular expansion reached by the classic 
mitogens was compared with that produced by EO by 
calculating the PI according to the following formula: 
PI = stimulated cells/ non-stimulated cells > 1.20 
(Tuchscherer et al., 2002). 
 CD4+ and CD8+ T cells and B cells quantification 
by immunofluorescence (IF) 
The CD4+ and CD8+ T cells present in the EO-
stimulated cultures were counted with the indirect IF 
technique using anti-human CD4 and anti-human 
(Sigma, St. Louis, US) CD8 monoclonal antibodies 
(Sigma, St. Louis, US), and B cells were counted with 
direct IF using anti-human γ-globulin-FITC (Sigma, 
St. Louis, US) (Edidin, 1989). 
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Table 1. Characterization of select allergic patients, including: age in years, symptoms, total IgE values and skin prick testing results. 
     Skin prick testing  with dust mite  
 
Nº clinical 
history 
Age 
(years) 
Symptoms IgE 
(UI/mL)* 
D.  pteronyssinus D.  farinae 
5 2 As Rh 618 ++ +++ 
9 5 Rh Ecz 190 +++ + 
10 5 As Rh 790 +++ ++ 
12 6 As Rh Sin Pr 1133 ++ +++ 
13 6 As Rh 1664 ++ + 
14 7 Rh, As 1236 ++ + 
15 8 Rh Si 365 + + 
16 8 As Rh 760 ++++ ++ 
18 9 As Rh 1000 + + 
20 11 Rh As 1321 ++ ++ 
21 11 As Rh 786 ++ ++ 
23 12 Rh Si 420 ++ ++ 
27 15 Rh 460 +++ +++ 
28 17 Rh Ecc 350 + + 
33 19 As Rh 512 ++++ ++ 
35 21 As Rh Ecz 122 + + 
36 21 As Rh Ecz 122 + + 
38 23 Rh Ecz 280 + + 
39 23 As Rh 139 + + 
41 26 As Rh 141 + + 
44 27 As 512 + + 
45 27 As RhEcz 123 + + 
47 28 Rh Ecz 790 + + 
50 29 As Ecz Rh 1560 + + 
51 29 As Rh Sin Pr 1133 ++ +++ 
52 29 As Rh 355 + + 
53 29 Rh, As 236 ++ + 
54 30 As Ecz Rh 568 + + 
55 30 As Rh Sin Pr 1233 ++ +++ 
56 30 As Rh 965 + + 
57 30 Rh, As 1236 ++ + 
 
As - Asthma; Rh - Rhinitis; Ecz - Eczema; Pr - Prurigo; Si - Sinusitis.  D. Pteronyssinus - Dermatophagoides pteronyssinus; D. Farinae - 
Dermatophagoides farinae. Prick test: scale from + to ++++ according to Bousquet (1988).   
* IgE was measurement by ELISA Kit (Iema Well de Radim, Rome, Italy) 
 
IFN-γ and IL-13 measurement 
 IFN-γ and IL-13 synthesis was quantified in EO-
stimulated supernatants of PBMC cultures from 
allergic patients, collected at 60 h incubation to 
optimize the detection of cytokine levels. IFN-γ 
detection was performed using a commercial Human 
Interferon Gamma (Hu- IFN-γ) ELISA kit (PBL 
Biomedical Laboratories, USA) and the lower limit of 
detection for the cytokine assay was less than 2 pg/mL 
(Kelder et al., 1986). IL-13 detection was performed 
using a commercial EHIL13 Human Interleukin-13 
ELISA Kit (Pierce Endogen, France) and the lower 
limit of detection for the cytokine assay was less than 
7 pg/mL  (Ly et al., 2005). This assay was carried out 
with PBMC cultures stimulated with: a) allergen alone 
(a suspension of dust mite at 10.000 PNU/mL) and b) 
6 μg/mL of EO, plus allergen. As a control, these 
cytokines were quantified in PBMC cultures with 
media alone. Each instance was triplicated. 
 β-hexosaminidase enzyme release assay 
The effects of different concentrations (160, 80, 40, 
20, 10 and 1 μg/mL) of EO on the release of β- hexo-
saminidase enzyme were evaluated constructing a 
dose-response curve in a previous assay. It was 
observed that EO reduced the levels of enzyme 
released in a dose-dependent way. The concentration 
of 10 μg/mL was that which produced the highest 
diminution of the release of enzyme.  
Basophils of peripheral blood were obtained by 
density gradient using 6% of dextran 70 with NaCl 
0.9%. The interphase that contained the cells was 
centrifuged and re-suspended in RPMI-1640. An 
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aliquot from the cellular suspension was taken and the 
cells were dyed with Toluidine Blue that it dyes only 
basophils. The cellular count was realized in camera 
Fuch Rosenthal in optical microscope. The concen-
tration of basophils was increased 100 to 200 times 
after the treatment with dextran (from 1-2 to 128-256 
cells in 64 fields). It had contamination by other PMN, 
such as neutrophils and eosinophils. 
Fifty microliters of the basophil suspension at a 
concentration of 1 x 105 cells/mL were placed in each 
well of the 96-well microplate and pre-incubated for 
15 min at 37 °C with the specific allergen alone (dust 
mite suspension), and the allergen plus: a) 0.04 mg/mL 
dexamethasone (Sidus); b) 0.2 mg/mL theophylline 
(Phoenix); c) 0.2 mg/mL disodium cromoglicate 
(Phoenix); d) 0.05 mg/mL ipratropium bromide 
(Altana Pharma), or e) 10 μg/mL essential oil. The 
negative control values were obtained using RPMI-
1640 and the cells alone, without any allergen 
stimulation, in order to view unspecific spontaneous 
degranulation. In addition, montelukast (0.04 mg/mL) 
(Merck) was used as a negative control of β-
hexosaminidase enzyme inhibition because it acts in 
the late phase of the allergic reaction, inhibiting 
leukotriene receptors. Blank values were obtained 
using just the media or DMSO. Following incubation, 
50 μL of the chromogenic substrate for the enzyme β-
hexosaminidase (4-nitrophenyl-N-acetyl-β-D-glucosa-
minide) (Sigma-Aldrich, Inc, St. Louis, USA) 1 
mmol/L, was added to each well and dissolved in 0.1 
mol/L of citrate buffer, pH 5. The system was 
incubated at 37 ºC for 1 h. The reaction was stopped 
with 200 μL of carbonate buffer 0.1 M, pH 10.5 per 
well. The product of the cleavage (4-nitrophenol) was 
interpreted by reader ELISA (Labsystems Multiskan 
MS) at 405 nm (Shibata et al., 1996).  The percentage 
of β- hexosaminidase release inhibited was calculated 
according to the formula: Inhibition % = (A – B) x 
100/A, where A is the amount of β-hexosaminidase 
released by basophils in the presence of the specific 
allergen alone and B, in the presence of the allergen 
aggregates from the anti-allergic drugs or oil  (Na et 
al., 2002). 
Statistical analysis 
All of the values obtained in the assays carried out 
during this investigation were expressed in averages 
and standard deviation. The parameters were evaluated 
using the program GraphPad Prism version 4.0 (Inc. 
San Diego, USA, 2004) and compared with the 
parametric test t-Student for twin samples. Statistical 
differences were considered significant when the value 
was p <0.05. 
RESULTS  
Identification and quantification of essential oil 
compounds 
GC analysis revealed a composition not 
significantly different than those reported previously 
by the authors (Zygadlo et al., 1996; Cariddi et al., 
2007). The main components were pulegone 63.0%, 
menthone 16.4% and limonene 1.9%, accompanied by 
other minor terpenoid components such as α-pinene 
(0.2%), β-pinene (0.3%) and 1,8-cineole (0.1%) were 
found in lower quantities in accordance with previous 
reports.  
Lymphocyte response to stimulation with essential 
oil 
EO (6 μg/mL) stimulated the proliferation of 
lymphocyte from allergic patients, revealing 
significant statistical differences in comparison with 
the cultures lacking stimulus (p<0.0001) and no 
differences when compared to PHA (p=0.1396) or 
ConA (p=0.1749). The PI calculated for EO, PHA or 
ConA, were > 1.20, indicating cellular proliferation 
(Fig. 1).  
Absolute values of CD4+ and CD8+ T cells and B 
cells in cellular cultures stimulated with EO revealed 
an increase (p<0.002 to each one of cell types) in 
regard to the cultures without stimulus  (Table 2).  
In supernatants of EO-stimulated cultures, values of 
IFN-γ revealed an increase in regard to cultures 
without stimulus (p<0.001) and cultures stimulated 
with allergen alone (p<0.0001) (Fig. 2). IL-13 levels 
were greater in the cultures stimulated with allergen 
than in cultures without stimulus (p<0.0001). In 
allergen-stimulated cultures with EO, the levels of IL-
13 were visibly reduced in regard to cultures 
stimulated with the allergen alone (p<0.0001) (Fig. 2).  
Effects of essential oil on basophil degranulation  
Basophils of all the allergen-challenged patients 
released high amounts of β-hexosaminidase enzyme in 
comparison with the values of enzyme released 
spontaneously (p<0.01) (Fig. 3). The anti-allergic 
drugs, excluding montelukast, reduced the in vitro 
levels of released enzyme in comparison with 
basophils challenged with the allergen alone (p<0.02) 
(Fig. 3). This result demonstrated that the plant 
fraction did not reveal allergenic effects in vitro. The 
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addition of EO to allergen-challenged basophils 
reduced β-hexosaminidase liberation to the same 
levels as those of the spontaneous release of the 
enzyme. The inhibiting activity of the oil at 10 μg/mL 
on the enzyme was higher than the one produced by 
standard drugs at concentrations: 0.04 mg/mL of dexa-
methasone, 0.2 mg/mL of theophylline, 0.2 mg/mL of 
disodium cromoglicate and 0.05mg/mL of ipratropium 
bromide (p<0.05 for each one) (Fig. 3). The per-
centage of inhibition of β-hexosaminidase released 
under different treatments is shown in Table 3 and the 
essential oil is significantly active.   
 
Tabla 2. Average absolute values + SD of total leukocytes from allergic patients and T CD4+, T CD8+ and B cells in cultures without 
stimulus (W/S) or stimulated with essential oil (EO). 
W/S cultures  Cultures stimulated with EO n Total 
leukocytes/mm3 
 
CD4+ CD8+  
 
B cells  CD4+  
 
CD8+  
 
B cells 
 
22 
 
6432.6 + 1321,6 
 
 
1677 + 65 
 
714 +  60 
 
705 + 57 
  
2174 + 82 
 
988 + 60 
 
916 + 61 
 
 
Table 3.  Percentage + SD of inhibition of β-hexosaminidase enzyme release from basophils of allergic patients by anti-allergic drugs or 
essential oil. 
Anti-allergice drugs or essential oil   
n=57 
dexa theo crom Ip EO 
Inhibition (%) 44.8 + 8 47.6 + 10 44.7 + 7 46.9 + 5 54.2 + 7 
                      Dexa - dexamethasone; theo - theopylline; crom - disodium cromoglicate; Ip - ipratropium bromide; EO - essential oil. 
 
Figure 1. Proliferation of lymphocytes from allergic patients 
(n=57), stimulated with 6 μg/mL essential oil (EO) from M. 
verticillata, according to MTT colorimetric assay.  
Figure 2. Quantification of IFN-γ and IL-13 in supernatants of 
lymphocyte cultures from allergic patients (n=38).  
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 IFN-γ was quantified in lymphocyte cultures without stimulus or 
stimulated with 6 μg/mL essential oil (EO) from M. verticillata. 
IL-13 was quantified in lymphocyte cultures without stimulus, 
stimulated with allergen alone or stimulated with allergen and 
with  6 μg/mL EO from M. verticillata added. W/S, without 
stimuli; a vs b p= 0.1332; a vs c p<0.001; b vs c p<0.0001, d vs e 
p<0.0001; d vs f p<0.0001, e vs f p<0.0001. 
PHA (10 μg/mL) or ConA (5 μg/mL) were used as positive 
controls of proliferation, and lymphocyte cultures without 
stimulus, as negative controls. W/S, without stimuli; a vs d  p < 
0.0001; b vs d  p = 0.1396; c vs d  p = 0.1749;  PI (PHA) = 1.81 + 
0.12; PI (ConA) = 1.90 + 0.11; PI (EO) = 1.87 + 0.10 
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Figure 3.  The amount of β-hexosaminidase enzyme released by 
allergen-challenged basophils from allergic patients (n=57) was 
reduced by essential oil (EO) and several anti-allergic drugs, 
excluding montelukast.  
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Basophils were incubated with EO alone, without allergen, and 
no significant liberation of the enzyme was observed. Cells 
without the addition of allergen and cells with addition of 
dimethylsulfoxide (DMSO) were also evaluated as controls. 
a vs c  p< 0.0001; a vs b  p = 0.3373; b vs c  p <0.002; c vs d  p < 
0.01; c vs e  p < 0.002; c vs f   p< 0.01; c vs g  p < 0.002; c vs h  p 
< 0.0001; c vs i  p = 0.8245;  h  vs * p = ns;  h vs i  p<0.0001;  d 
vs i  p < 0.01; e vs i  p< 0.002; f vs i  p< 0.02; g vs i p<0.003. 
blank, media alone; DMSO, dimethylsulfoxide; bas, basophils; 
allerg, allergen ; dexa, dexamethasone ; theo, theopylline ; crom, 
disodium cromoglicate; iprat, ipratropium bromide;  EO, essential 
oil; mont, montelukast 
DISCUSSION  
In the present study, the essential oil from M. 
verticillata was composed mainly by mono-and 
sesquiterpenes. Zygadlo et al. (1996) analyzed oils of 
M. verticillata of different geographic areas from 
Argentina. They found that the main components are 
terpenes and seem to be divided in three chemotypes: 
carvone, thymol-carvacrol and predominantly 
pulegone-menthone. Our results agree those of De 
Feo et al. (1998), González Pereyra et al. (2005), 
Cariddi et al. (2007), Maldonado et al. (2007), who 
studied M. verticillata oil and reported the 
composition.  
At optimal concentrations, EO from M. 
verticillata was able to stimulate in vitro the 
lymphocyte proliferation in patients allergic to dust 
mites with effects similar to those of PHA or ConA. 
These lectins bond specifically to carbohydrate 
components, including proteins of the TcR-CD3 
complex. This produces the activation of several 
types of enzymatic routes which involve Ras-Map 
kinases, calcium-dependent PLCγl and PLCγl–DAG, 
key participants in cellular proliferation, differen-
tiation and apoptosis (Crespo & Gutkind, 2004).  
According to some authors in vitro studies of 
allergic patients have shown increased values of 
CD4+ T cells (1500-1750 cells/mm3), differentiating 
towards the Th2 profile; a decrease in CD8+ T cells 
(370-520 cells/mm3) (Bratke et al., 2006) and high 
values of B cells (480-650 cells/mm3) (Mohamed et 
al., 2003) in comparison with non-allergic 
individuals. In this study EO (6 μg/mL) increased in 
vitro absolute values for both T CD4+ and CD8+ cells 
subpopulations in patients allergic to dust mites, 
indicating that this plant fraction stimulated cellular 
immunity. These data are compatible with those from 
a previous in vitro study in which high EO 
concentrations (mg/mL) increased values of CD8+ T 
cells in both patients allergic to environmental fungi 
and healthy individuals alike (Cariddi et al., 2006).  
The EO also increasing the absolute values of B 
cells. Previously we demonstrated that EO had effects 
similar to those of PWM, mitogen of B and T cells, 
on lymphocyte proliferation in both allergic and 
healthy individuals (Cariddi et al., 2005). These 
results correspond with those of this investigation, 
where we demonstrated that EO was able to stimulate 
both T and B cells. 
Treatment with the EO increased the levels of 
IFN-γ, which is why it is suggested that the EO-ac-
tivated CD4+ T cells in this study could be Th1 cells, 
which produce IFN-γ. EO was able to stimulate in 
vitro CD8+ T cells as well, also producers of IFN-γ. 
In addition, we observed that EO reduced IL-13 
values in lymphocyte cultures co-stimulated with the 
allergen, as compared to cultures stimulated with 
allergen alone. These data demonstrated that EO mo-
dulated the in vitro Th1/Th2 response, favoring Th1 
deviation. Anti-allergic therapies aim to redirect the 
profile of Th2 cells towards Th1, increasing IFN-γ 
synthesis and decreasing IL-4 and IL-13 values, thus 
reducing IgE levels (Bang & Plosker, 2004). It was 
confirmed that the vegetal derivative acts on the 
immune response by means of the stimulation of the 
Th1 profile. In previous studies this was deduced of 
the cuantification of IFN-γ and LT CD8+ (Cariddi et 
al., 2006, 2007; Maldonado et al., 2007). 
β-hexosaminidase, an acid hydrolase, is released 
along with histamine when basophils are activated. 
Therefore, β-hexosaminidase is accepted as a 
degranulation marker (Shibata & Yagi, 1996). 
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During the β-hexosaminidase enzyme release 
assay, we confirmed that the anti-allergic drugs 
tested, excluding montelukast, were able to reduce 
the levels of enzyme released, as compared to 
basophils challenged with allergen alone. 
Dexamethasone, in addition to bonding to the 
cytoplasmic specific receptor that enters the nucleus 
and attaches itself to the DNA, works by stimulating 
cAMP production, inhibiting the degranulation 
process in basophils and mast cells (Fukui, 2008). 
Theophylline acts as inhibitor of phosphodiesterase. 
This enzyme deactivates cAMP forming icAMP, 
which favors cell degranulation (Lipworth, 2005). 
Cromoglycate is a basophil and mast cell membrane 
stabilizer, as it prevents their degranulation (Gotua et 
al., 2008). Ipratropium inhibits the liberation of 
chemical mediators, increased by acetylcholine, by 
blocking cholinergic receptors on the surface of 
basophils and mast cells (Spooner et al., 2003). In 
contrast, montelukast, a leukotriene receptor 
antagonist (Kawai et al., 2008), which was used in 
this study as a negative control for inhibition of the 
immediate reaction, did not decrease the levels of β-
hexosaminidase released by basophils challenged 
with allergen, as expected in this model.  
EO, at a concentration of 10 μg/mL, reduced the 
levels of β-hexosaminidase released by basophils, 
with effects majors to the anti-allergic drugs tested, 
excluding montelukast, which is why it has been 
suggested that this plant fraction could act upon cell 
membranes with a mechanism similar to that of one 
of these drugs. These results demonstrated that EO 
maintained its inhibiting properties on basophil 
degranulation at high (Cariddi et al., 2006) and small 
concentrations alike. 
Some of main components of EO identified by GC 
could be responsible for its biological activity. 
Numerous investigations demonstrate the protective 
effects of terpenes on cell membranes. These 
substances also carry out a regulating activity on T 
cells, the synthesis of cytokines and inhibition of the 
apoptosis processes (Yeh et al., 2006; Ashibe et al., 
2007). 
Essential oils are complex mixtures of numerous 
molecules and their biological effects are the result of 
a synergy between all of them or the reflection of 
main molecules present at high levels according to 
analysis by GC (Bakkali et al., 2008).  
According to the aforementioned, EO could have 
displayed protective effects on cell membranes when 
added to the basophils. This indicates that the 
increase in basophil membrane permeability may be 
an essential trigger for the release of β-hexo-
saminidase. The terpenes from EO may have acted 
upon basophil membranes, avoiding the disturbance 
induced by the specific allergen. There would not be 
modifications related at least to types of allergens 
both tried (fungi and dust mite) (González Pereyra et 
al., 2005; Cariddi et al., 2006, 2007; Maldonado et 
al., 2007). Moreover the active concentrations seem 
to be much lower than previously thought, as this 
work found activity in the range 6 mg/ml at 0.006 
µg/mL, in contrast with our previous tests at only 150 
mg/mL (Cariddi et al., 2005). 
CONCLUSION 
The EO from leaves of Minthostachys verticillata 
at small concentrations acted as a mitogen, increasing 
proliferation of T and B cells from allergic patients. 
As an immunomodulator, it favored Th1 deviation by 
increasing IFN-γ synthesis and decreasing IL-13 pro-
duction. EO maintained its inhibiting effects on baso-
phil degranulation, reducing the levels of β-hexo-
saminidase released. 
Additional studies are being realized along the 
same line of investigation to reveal if the terpenes 
identified can have therapeutic applications in 
allergies. In the future, these products could be 
applied in alternative or complementary therapies 
with patients who do not respond to conventional 
treatment. 
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